The document is an intimation regarding the availability of a transcript for an earnings conference call.
The event type is an earnings conference call for the discussion of quarterly results.
The call was held on October 28, 2026.
The transcript pertains to the company's financial results for Q2 FY2027.
The transcript has been uploaded to the company's website and is available at the provided link: https://www.syngeneintl.com/investors/financial-information/.
The specific path on the website to locate the transcript is: Financial Information ▸ FY 2027 ▸ Q2 ▸ IR Call Transcript.
The disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The management participants for the call are not listed in this specific intimation notice.
The notice does not indicate whether any unpublished price sensitive information (UPSI) was or will be shared; it solely intimates the availability of a past call's transcript.
Additional Notes Section
This is a formal regulatory filing submitted to BSE Limited and the National Stock Exchange of India Limited.
The document is signed by Chethan Yogesh, who is identified as the Company Secretary & Compliance Officer.
The intimation letter bears the reference number: Ref: Syn/CS/SE/BM/2026-27/Nov/01 and is dated November 02, 2026.
No financial data, guidance, or strategic updates are disclosed in this announcement. This is purely an intimation of the transcript's availability.
